Atonomics gains major investment for diagnostic chip development  

2005.08.17
Danish medico company Atonomics has raised DKK 67 mn (USD 11.4 mn) in new capital for development of a diagnostic biochip

Danish medico company Atonomics has raised DKK 67 mn (USD 11.4 mn) in new capital for development of a diagnostic biochip. The investment consortium consists of the Swiss investment fund Inventages, Japanese electronic group Murata, Danish biopharmaceutical company NeuroSearch and the Danish Fund for Industrial Growth.

Atonomics has developed a new biosensor technology which can detect biomolecules through specific affinity reactions on a gold surface by means of surface acoustic waves (SAW), also used in mobile phones. The chip which is under development, will reportedly be able to measure human gene proteins, enabling faster and more precise diagnosis of a number of life threatening diseases.

Thomas Warthoe, managing director of Atonomics says: "Now the human genome has been mapped, there will be a great need in the future for being able to measure specific proteins both very rapidly and in extremely small quantities. This chip will be able to do that".

The electronic components for the chip will be supplied by Murata. Atonomics expects to have the first version of the chip developed in a year, after which it will be tested before launch. The news is reported by national daily newspaper Jyllands-Posten.

Link > Atonomics 

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×